Markers of Memory CD8 T Cells Depicting the Effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan

BNT162b2, a nucleoside-modified mRNA vaccine for SARS-CoV-2 spike glycoprotein (S), provides approximately 95% efficacy for preventing COVID-19. However, it remains unclear how effectively memory CD8+ T cells are generated and which genetic and environmental factors affect the generation and functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Hiroyuki, Kageyama, Takahiro, Tanaka, Shigeru, Otsuka, Kunihiro, Tsukumo, Shin-ichi, Mashimo, Yoichi, Onouchi, Yoshihiro, Nakajima, Hiroshi, Yasutomo, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096866/
https://www.ncbi.nlm.nih.gov/pubmed/35572546
http://dx.doi.org/10.3389/fimmu.2022.836923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096866/
https://www.ncbi.nlm.nih.gov/pubmed/35572546
http://dx.doi.org/10.3389/fimmu.2022.836923

Ejemplares similares